Simplex Trading, LLC Calliditas Therapeutics Ab Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$20.04 - $25.66 $6,953 - $8,904	347 Added 107.1%	671 $14,000
Q4 2023 Feb 02, 2024	SELL	$15.79 - $28.99 $3,347 - $6,145	-212 Reduced 39.55%	324 $8,000
Q3 2023 Nov 01, 2023	SELL	$15.68 - $20.38 $9,455 - $12,289	-603 Reduced 52.94%	536 $9,000
Q2 2023 Aug 04, 2023	BUY	$15.7 - $25.61 $17,882 - $29,169	1,139 New	1,139 $18,000
Q4 2022 Feb 02, 2023	SELL	$11.5 - $19.6 $1,207 - $2,058	-105 Reduced 36.21%	185 $3,000
Q3 2022 Nov 04, 2022	BUY	$14.12 - $22.49 $4,080 - $6,499	289 Added 28900.0%	290 $4,000
Q2 2022 Aug 03, 2022	BUY	$12.85 - $20.36 $12 - $20	1 New	1 $0
Q1 2022 May 02, 2022	SELL	$15.14 - $25.55 $17,925 - $30,251	-1,184 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$15.04 - $26.32 $17,807 - $31,162	1,184 New	1,184 $29,000

825K

8.5K

26.6K

Ticker CALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,624,800
Market Cap $1.06B
Description
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.